NNP
IART icon

Nachman Norwood & Parrott’s Integra LifeSciences IART Stock Holding History

Nachman Norwood & Parrott’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-214
Closed -$10K – 610
2020
Q3 		$10K Buy
+214
New +$10.2K ﹤0.01% 755

Other funds holding IART

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nachman Norwood & Parrott's IART Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of Integra LifeSciences (IART) in Q4 2020, closing a stake of 214 shares — an estimated $10K sold.

Nachman Norwood & Parrott first reported a position in IART in Q3 2020 and held it in 1 quarter. The position peaked at $10K in Q3 2020. 251 funds tracked by Wall St. Rank hold IART as of Q4 2020.

  • Nachman Norwood & Parrott reported no remaining Integra LifeSciences position as of Q4 2020 after selling out during the quarter.
  • Nachman Norwood & Parrott sold 214 Integra LifeSciences shares in Q4 2020, an estimated $10K.
  • Nachman Norwood & Parrott first reported a position in Integra LifeSciences in Q3 2020 and held it in 1 quarter.
  • Nachman Norwood & Parrott's Integra LifeSciences position peaked at $10K in Q3 2020.
  • 251 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.